Showing results (51-60 of 86) with videos related to

Sort By:
Pageof 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2001
Pharmacokinetic/pharmacodynamic study of ZD9331, a nonpolyglutamatable inhibitor of thymidylate synthase, in a murine model following two curative administration schedulesG W Aherne, A Hardcastle, E Ward, et al.
Advances in Enzyme Regulation|January 1, 1989
Thymidylate synthase: a target for anticancer drug designK R Harrap, A L Jackman, D R Newell, et al.
Journal of Medicinal Chemistry|March 1, 1991
Quinazoline antifolates inhibiting thymidylate synthase: 4-thio-substituted analoguesT J Thornton, T R Jones, A L Jackman, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1996
Preclinical pharmacology of CB30900, a novel dipeptide inhibitor of thymidylate synthase, in miceM I Walton, W Gibson, G W Aherne, et al.
Anti-Cancer Drug Design|December 1, 1996
Prodrugs of thymidylate synthase inhibitors: potential for antibody directed enzyme prodrug therapy (ADEPT)C J Springer, V Bavetsias, A L Jackman, et al.
Journal of Medicinal Chemistry|October 3, 1999
Design and synthesis of potent non-polyglutamatable quinazoline antifolate thymidylate synthase inhibitorsP R Marsham, J M Wardleworth, F T Boyle, et al.
Pageof 9